Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 10, Issue 12, pp. 2257-2266
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 9, 2011
- Revision received August 24, 2011
- Accepted September 16, 2011
- Published first October 6, 2011.
Article Versions
- Previous version (October 6, 2011 - 12:35).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- Michael F. Emmons1,4,
- Anthony W. Gebhard1,5,
- Rajesh R. Nair1,
- Rachid Baz2,
- Mark L. McLaughlin3,6,
- Anne E. Cress7, and
- Lori A. Hazlehurst1,2,4,5
- Authors' Affiliations: 1Molecular Oncology Program; 2Hematology Malignancies Program; 3Drug Discovery Department, Moffitt Cancer Center; 4Cancer Biology Program; 5Molecular Pharmacology and Physiology Program; 6Department of Chemistry, University of South Florida, Tampa, Florida; and 7Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona
- Corresponding Author:
Lori A. Hazlehurst, Molecular Oncology Program, H Lee Moffitt Cancer Center Tampa, FL. Phone: 813-903-6807; Fax: 813-979-7265; E-mail: Lori.Hazlehurst{at}moffitt.org
December 2011
Volume 10, Issue 12
Volume 10, Issue 12
Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype
Jump to section
Advertisement